Ectopic Pregnancy Risk in Users of Levonorgestrel-Releasing Intrauterine Systems With 52, 19.5, and 13.5 mg of Hormone

Amani Meaidi; Christian Torp-Pedersen; Øjvind Lidegaard; Lina Steinrud Mørch

doi:10.1001/jama.2023.0380

Ectopic Pregnancy Risk in Users of Levonorgestrel-Releasing Intrauterine Systems With 52, 19.5, and 13.5 mg of Hormone

JAMA. 2023 Mar 21;329(11):935-937. doi: 10.1001/jama.2023.0380.

Authors

Amani Meaidi¹, Christian Torp-Pedersen², Øjvind Lidegaard³, Lina Steinrud Mørch¹

Affiliations

¹ The Danish Cancer Society Research Center, Cancer Surveillance and Pharmacoepidemiology, Copenhagen, Denmark.
² Department of Cardiology, North Zealand Hospital, Hilleroed, Denmark.
³ Department of Gynecology, Rigshospitalet, Copenhagen, Denmark.

No abstract available

Plain language summary

This study assesses the association between use of levonorgestrel intrauterine systems containing 52, 19.5, and 13.5 mg of hormone and ectopic pregnancy in a nationwide cohort study.

MeSH terms

Contraceptive Agents, Female / administration & dosage
Contraceptive Agents, Female / adverse effects
Female
Hormones
Humans
Intrauterine Devices* / adverse effects
Levonorgestrel* / administration & dosage
Levonorgestrel* / adverse effects
Pregnancy
Pregnancy, Ectopic* / chemically induced
Pregnancy, Ectopic* / etiology

Substances

Contraceptive Agents, Female
Hormones
Levonorgestrel